Usefulness of the Duke Sudden Cardiac Death Risk Score for Predicting Sudden Cardiac Death in Patients With Angiographic (>75% Narrowing) Coronary Artery Disease

American Journal of Cardiology

Volumn 104, Issue 12, 2009, Pages 1624-1630

  Atwater, Brett D ^a,b   Thompson, Vivian P ^a   Vest III, Richard N ^c   Shaw, Linda K ^a   Mazzei Jr , Walter R ^d   Al Khatib, Sana M ^a,b   Hranitzky, Patrick M ^a,b   Bahnson, Tristram D ^a,b   Velazquez, Eric J ^a,b   Califf, Robert M ^a,b,e   Lee, Kerry L ^a   Roe, Matthew T ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TEXAS HEART INSTITUTE   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DEMOGRAPHY; DIABETES MELLITUS; EXTERNAL VALIDITY; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SMOKING; STATISTICAL MODEL; SUDDEN DEATH;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS;

EID: 70749126660     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.07.042     Document Type: Article

References (9)

1. Hlatky M.A., Califf R.M., Harrell F.E., Lee K.L., Mark D.B., and Pryor D.B. Comparison of predictions based on observational data with the results of randomized controlled trials of coronary artery bypass surgery. J Am Coll Cardiol 11 (1988) 237-245
2. Mark D.B., Nelson C.L., Califf R.M., Harrell F.E., Lee K.L., Jones R.H., Fortin D.F., Stack R.S., Glower D.D., and Smth L.R. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation 89 (1994) 2015-2025
3. Newby L.K., Lapointe N.M., Chen A.Y., Kramer J.M., Hammill B.G., DeLong E.R., Muhlbaier L.H., and Califf R.M. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 113 (2006) 203-212
4. Heymans M.W., Buuren S.V., Knol D.L., van Mechelen W., and de Vet H.C.W. Variable selection under multiple imputation using bootstrap in a prognostic study. BMC Med Res Methodol 7 (2007) 33
5. Hanley J.A., and McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29-36
6. Ohman E.M., Granger C.B., Harrington R.A., and Lee K.L. Risk stratification and therapeutic decision making in acute coronary syndromes. JAMA 284 (2000) 876-878
7. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., McNulty S.E., Clapp-Channing N., Davidson-Ray L.D., Fraulo E.S., Fishbein D.P., Luceri R.M., and Ip J.H. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
8. Packer D.L., Bernstein R., Wood F., Boehmer J., Carlson M., Frantz R.P., Mitchell B., McNulty S.E., Poole J.E., Rogers J., Anderson J., Walsh M.N., Lee K.L., Bardy G.H., Bouineau R., and Domanski M. Impact of amiodarone versus implantable cardioverter defibrillator therapy on the mode of death in congestive heart failure patients in the SCDHeFT trial. Heart Rhythm 2 S38 (2005) AB20-AB22
9. Owens D.K., Sanders G.D., Heidrenreich P.A., McDonald K.M., and Hlatky M.A. Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. Am Heart J 144 (2002) 440-448